Sichuan's self-researched “three-seven-sodium saponin” Chinese medicine extract standard entered the 2018 edition of the German Drug Code for the first time, which is a solid step for the internationalization of Chinese medicine and Chinese medicine standards. This is what the reporter learned from the “Complete Registration Forum of Chinese Medicine EU” held in Chengdu recently.
“Sichuan Chinese medicine extract standards entered the German Drug Code for the first time, which means that the spread of Chinese medicine in Europe has made a breakthrough,” said Gerhard Franz, chairman of the German Pharmacopoeia Botanical Committee.
The reporter learned that "three-seven saponins" is a traditional Chinese medicine extract developed by Chengdu Taihe Health Technology Group Co., Ltd., which is used in the production of traditional Chinese medicine Sanqi Tongshu Capsule. The variety is used for the prevention and treatment of cardiovascular and cerebrovascular diseases, and its pharmacodynamic substance foundation is clear, the mechanism of action is clear, and the clinical curative effect is remarkable.
"Chinese medicine and traditional Chinese medicine compound preparations have not obtained legal status in Europe and the United States, but foreign countries have set up an international research organization, which shows their expectations for Chinese medicine." Yao Xinsheng, an academician of the Chinese Academy of Engineering, believes that Sichuan traditional Chinese medicine extract standards first entered The German Drug Code is an example. On this basis, the pace of internationalization of Chinese medicine will gradually accelerate in the future. (Reporter Dong Xiaohong)